Related Experiment Video

Updated: Mar 13, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

19.0K

An Update on Treatment and Management of Pediatric Systemic Lupus Erythematosus

Amit Thakral1, Marisa S Klein-Gitelman2

  • 1Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Chicago, IL, USA. athakral@luriechildrens.org.

Rheumatology and Therapy
|October 18, 2016
PubMed

Insights

Childhood-onset systemic lupus erythematosus (SLE) requires early immunosuppression for better outcomes. Multidisciplinary care and patient education are crucial for managing this lifelong condition in children.

Area of Science:

  • Pediatric Rheumatology
  • Autoimmune Diseases
  • Immunology

Background:

  • Systemic lupus erythematosus (SLE) affects 20% of patients in childhood, presenting unique challenges.
  • Childhood-onset SLE (cSLE) carries higher morbidity and mortality risks compared to adult-onset disease.
  • Effective management aims to reduce disease activity and enhance quality of life through early intervention.

Approach:

  • A multidisciplinary team approach is essential for managing the complexities of pediatric SLE.
  • Early immunosuppressive therapy is a cornerstone of treatment to control disease progression.
  • Empowering young patients with disease ownership prepares them for lifelong self-management.

Key Points:

  • cSLE necessitates aggressive management strategies.
  • Integrated care involving various specialists optimizes treatment outcomes.
  • Patient and family education is vital for adherence and long-term well-being.

Conclusions:

  • Current pediatric SLE management focuses on early, aggressive, and multidisciplinary care.
  • Long-term outcomes are improved by addressing disease activity and fostering patient self-efficacy.
  • Continued research into optimal pediatric SLE treatment protocols is warranted.

Keywords:
AutoimmuneManagementMedicationPediatricRheumatologySystemic lupus erythematosusTreatment

More Related Videos

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.6K
Murine Bilateral Renal Lymphadenectomy06:20

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

130

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
294
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
412
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
309
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
451
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
728